PT95515A - Processo para a preparacao de derivados da quinolina e de composicoes farmaceuticas qoe os contem - Google Patents

Processo para a preparacao de derivados da quinolina e de composicoes farmaceuticas qoe os contem Download PDF

Info

Publication number
PT95515A
PT95515A PT95515A PT9551590A PT95515A PT 95515 A PT95515 A PT 95515A PT 95515 A PT95515 A PT 95515A PT 9551590 A PT9551590 A PT 9551590A PT 95515 A PT95515 A PT 95515A
Authority
PT
Portugal
Prior art keywords
methyl
dihydro
compound
formula
chloro
Prior art date
Application number
PT95515A
Other languages
English (en)
Portuguese (pt)
Inventor
Kanji Meguso
Hitoshi Ikeda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of PT95515A publication Critical patent/PT95515A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Measurement Of Radiation (AREA)
  • Holo Graphy (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT95515A 1989-10-06 1990-10-04 Processo para a preparacao de derivados da quinolina e de composicoes farmaceuticas qoe os contem PT95515A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26278289 1989-10-06
JP32229089 1989-12-11

Publications (1)

Publication Number Publication Date
PT95515A true PT95515A (pt) 1991-08-14

Family

ID=26545706

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95515A PT95515A (pt) 1989-10-06 1990-10-04 Processo para a preparacao de derivados da quinolina e de composicoes farmaceuticas qoe os contem

Country Status (17)

Country Link
US (1) US5223513A (enExample)
EP (1) EP0421456B1 (enExample)
KR (1) KR910007883A (enExample)
CN (1) CN1050715A (enExample)
AT (1) ATE116301T1 (enExample)
AU (1) AU629048B2 (enExample)
CA (1) CA2026890C (enExample)
DE (1) DE69015541T2 (enExample)
FI (1) FI904915A7 (enExample)
HU (1) HUT55364A (enExample)
IE (1) IE903454A1 (enExample)
IL (1) IL95839A (enExample)
NO (1) NO904300L (enExample)
NZ (1) NZ235582A (enExample)
PT (1) PT95515A (enExample)
RU (1) RU2001910C1 (enExample)
TW (1) TW205037B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03181465A (ja) * 1989-12-11 1991-08-07 Takeda Chem Ind Ltd キノリン誘導体
AU1879792A (en) * 1991-04-26 1992-12-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatives
ATE175196T1 (de) * 1992-01-23 1999-01-15 Pfizer 4-phenyl-3-(heteroarylureido)-1,2-dihydro-2- oxochinolin derivate, als antihypercholesterolemische und antiatherosklerotische mittel
TW241258B (enExample) * 1992-04-15 1995-02-21 Takeda Pharm Industry Co Ltd
RU94046149A (ru) * 1992-05-28 1996-11-27 Пфайзер Инк. (US) Новые n-арил и n-гетероарил производные мочевины как ингибиторы ацил кофермента а:холестерин ацил трансферазы (асат) фармацевтическая композиция, способ ингибирования (асат)
DE69315920T2 (de) * 1992-09-04 1998-06-10 Takeda Chemical Industries Ltd Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
TW263498B (enExample) * 1993-11-10 1995-11-21 Takeda Pharm Industry Co Ltd
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
JP2001513560A (ja) * 1997-08-28 2001-09-04 ブリストル−マイヤーズ スクイブ カンパニー 4−アリール−3−アミノキノリン−2−オン誘導体カリウムチャンネル調節剤
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
WO1999043659A1 (en) 1998-02-25 1999-09-02 Sumitomo Pharmaceuticals Co., Ltd. Pyridone derivatives and process for producing the same
JP2002531549A (ja) * 1998-12-04 2002-09-24 ブリストル−マイヤーズ スクイブ カンパニー カリウムチャネル・モジュレーターとしての3−置換−4−アリールキノリン−2−オン誘導体
HUP0301010A3 (en) * 2000-02-02 2005-03-29 Warner Lambert Co Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders and pharmaceutical compositions containing them
EP1375487B1 (en) * 2001-03-02 2011-08-24 Sumitomo Chemical Company, Limited Process for producing quinoline-3-carboxylic acid compounds
CA2445623A1 (en) * 2001-04-30 2002-11-07 Pfizer Products Inc. Methods for preparing cetp inhibitors
CA2539760C (en) 2003-09-23 2011-01-25 Merck & Co., Inc. Quinoline potassium channel inhibitors
SG11201401937YA (en) * 2011-11-04 2014-05-29 Hoffmann La Roche New aryl-quinoline derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1216878B (de) * 1963-04-02 1966-05-18 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von coronargefaesserweiternden Derivaten des 7-Hydroxy-2-oxo-1, 2-dihydrochinolins
NO133758C (enExample) * 1970-04-04 1976-06-23 Takeda Chemical Industries Ltd
JPS555502B1 (enExample) * 1971-07-31 1980-02-07
US4530931A (en) * 1983-01-03 1985-07-23 Usv Pharmaceutical Corp. 8-Quinoline carbanilates for the inhibition of lipolysis
DE3586445T2 (de) * 1984-06-26 1993-01-14 Merck & Co Inc Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen.
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use

Also Published As

Publication number Publication date
IL95839A (en) 1995-03-15
CN1050715A (zh) 1991-04-17
DE69015541D1 (de) 1995-02-09
HUT55364A (en) 1991-05-28
ATE116301T1 (de) 1995-01-15
HU906360D0 (en) 1991-04-29
DE69015541T2 (de) 1995-06-01
CA2026890C (en) 2001-09-18
RU2001910C1 (ru) 1993-10-30
AU629048B2 (en) 1992-09-24
NO904300D0 (no) 1990-10-03
EP0421456B1 (en) 1994-12-28
CA2026890A1 (en) 1991-04-07
FI904915A7 (fi) 1991-04-07
NO904300L (no) 1991-04-08
IL95839A0 (en) 1991-06-30
US5223513A (en) 1993-06-29
EP0421456A3 (en) 1991-05-29
TW205037B (enExample) 1993-05-01
JPH03223254A (ja) 1991-10-02
NZ235582A (en) 1992-03-26
KR910007883A (ko) 1991-05-30
IE903454A1 (en) 1991-04-10
FI904915A0 (fi) 1990-10-05
AU6370790A (en) 1991-04-11
EP0421456A2 (en) 1991-04-10

Similar Documents

Publication Publication Date Title
DE69616323T2 (de) Aromatische verbindungen und diese enthaltende pharmazeutische zusammenstellungen
EP0218999B1 (en) New quinazoline derivatives, process for their production and pharmaceutical compositions comprising them
US5155110A (en) Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
CA3063111C (en) Histone deacetylases (hdacs) inhibitors
DE69618210T2 (de) Aromatische verbindungen und diese enthaltende pharmazeutische zusammenstellungen
RU2001910C1 (ru) Способ получени хинолинового производного
OA11547A (en) Quinoline derivatives.
SK285618B6 (sk) N-Substituované indol-3-glyoxylamidy s antiastmatickým, antialergickým a imunosupresívnym/imunomodulujúcim účinkom, použitie týchto zlúčenín na výrobu liečivého prípravku, liečivý prípravok obsahujúci N-substituované indol-3-glyoxylamidy, spôsob výroby liečivého prípravku a spôsob výroby N-substituovaných indol-3-glyoxylamidov
US3482024A (en) Therapeutic treatment with 1,2-dihydro-1,2,4-benzotriazine derivatives
RU2130934C1 (ru) Производные хинолина и хиназолина, способ их получения и фармацевтическая композиция
UA43853C2 (uk) Арилалкілпіридазинони, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
JPH01258664A (ja) キノリン、その製造法および抗腫瘍作用を有するキノリン含有医薬組成物
EP0335586A1 (en) Piperidine & piperazine derivatives, process for preparing the same and pharmaceutical compositions containing the same
US4216160A (en) Substituted mercapto acid amides and their use
US4608384A (en) Thieno[2,3-b] pyrrole compounds and analgesic use thereof
DE3853608T2 (de) Zyklische Anthranil-carbonsäurederivate und Verfahren zu deren Herstellung.
US3798226A (en) 3-acylamino-4-phenylquinolines carrying a substituent on the benzene ring
US3415834A (en) Derivatives of 2-anilino-nicotinic acid and process for their preparation
EP0422051A1 (en) Condensed pyrazole 3-oxo-propanenitrile derivatives and process for their preparation
PT86677B (pt) Processo para a preparacao de cinolina-carboxamidas e de composicoes farmaceuticas que as contem
JPH0327363A (ja) チオウラシル誘導体
US5250541A (en) Kynurenic acid derivatives, their preparation and pharmaceutical compositions containing them
JPS6335623B2 (enExample)
JPS6229585A (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置2で置換された4―ohキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
US4287126A (en) (2-Oxo-2H-1-benzopyran-3-yl)aminooxoacetic acids and their derivatives

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910306

FC3A Refusal

Effective date: 19961010